Extração e purificação de fármacos anti-inflamatórios não esteroidais ciclo-oxigenase-2 seletivos


Autoria(s): Moreira,Tailane Sant'Anna; Cid,Yara Peluso; Pierre,Maria Bernadete Riemma; Sousa,Valeria Pereira de; Kummerle,Arthur Eugen; Fraga,Carlos Alberto Manssour
Data(s)

01/01/2009

Resumo

Celecoxib (CB) and lumiracoxib (LM) are potent COX-2 inhibitors widely marketed for the treatment of rheumatoid arthritis and osteoarthritis. Nevertheless, it is difficult to obtain because it are protected under patents. The aim of this work was to develop an extraction method of drugs, CB and LM, in order to obtain the drug with a purity degree appropriated for use in research projects. The developed method showed to be effective of both drugs, becoming interesting due to its low cost, easy and speed of execution, application to different dosage forms (capsules and tablets) and drugs with different physicochemical properties.

Formato

text/html

Identificador

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422009000500040

Idioma(s)

pt

Publicador

Sociedade Brasileira de Química

Fonte

Química Nova v.32 n.5 2009

Palavras-Chave #celecoxib #lumiracoxib #extraction
Tipo

journal article